Agenda

*Agenda as of October 12, 2021. Please note, agenda is subject to change. 
**All times are Eastern Standard Time.

 

Day 1 - Monday, October 18, 2021

 

11:00 a.m. Welcome Remarks 

• Mary Weiser, Chair, FARE Board of Directors

11:05 a.m. Keynote – Stanford University Research Followed by Live Discussion

• Diagnostics for Food Allergy
  • Tina Sindher, MD, Stanford University
• Therapeutic Innovations in Food Allergy
  • Sharon Chinthrajah, MD, Stanford University
• D-Prevention for Food Allergy
  • Kari Nadeau, MD, PhD, Stanford University
• Live Discussion
  • Sharon Chinthrajah, MD, Tina Sindher, MD

12:20 p.m. Break

1:00 p.m. Disease Development

• T Cells and Response to Food Allergen Immunotherapy
  • Celia Berin, PhD, Icahn School of Medicine at Mount Sinai
• Skin Barrier Dysfunction in Food Allergy
  • Donald Leung, PhD, MD, National Jewish Health  
• A Non-Canonical Function of the Immune System: Intestinal Adaption of Nutrient Availability
  • Ruslan Medzhitov, PhD, Yale School of Medicine
• Dietary and Microbiome Effects 
  • Uma Naidoo, MD, Massachusetts General Hospital
• Live Panel Discussion

3:00 p.m. Break

4:00 p.m. Diagnosis

• Addressing the Unmet Need in Food Allergy Diagnostics, Epitope-specific Antibody Profiling
  • Hugh Sampson, MD, AllerGenis
• Role of Regulatory T Cells in Inducing Natural Tolerance to Food & Successful Oral Immunotherapy
  • Rima Rachid, MD, Harvard/Boston Children’s Hospital
• FARE BBDC: Leveraging Biobanking for Food Allergy Research
  • Mike Pauciulo, MBA, Cincinnati Children’s Hospital
• Under the Banyan Tree: Tales of Biobank Facilitated Research
  • Amal Assa’ad, MD, Cincinnati Children’s Hospital
• Live Panel Discussion

6:15 p.m. Special Panel Discussion

• Implementation of Peanut Oral Immunotherapy
  • Moderated by: Edwin Kim, MD, MS, University of North Carolina
  • Katherine Anagnostou, MD, PhD, Baylor/Texas Children’s Hospital
  • Drew Bird, MD, UT Southwestern
  • Julie Wang, MD, Icahn School of Medicine at Mount Sinai
     

 

Day 2 - Tuesday, October 19, 2021

 

11:00 a.m. Treatment - Immunotherapy 

• Safety of PTAH in Children and Teenagers with Peanut Allergy
  • Kari Brown, MS, Aimmune
• Clinical Updates for Viaskin™ Peanut
  • Pharis Mohideen, MD, DBV Technologies 
• Immunotherapy - Identifying Better Predictors of Success
  • Wayne Shreffler, MD, PhD, Massachusetts General Hospital
• Anti-allergen Monoclonal Antibodies – Potential Paradigm Switch
  • Jennifer Maloney, MD, Regeneron
• Live Panel Discussion

1:00-2:00 p.m. Break

2:00 p.m. Immunotherapy and FARE Clinical Network

• Late-Stage Respiratory Pipeline
  • Thomas Corbridge, MD, GlaxoSmithKline
• Children’s Hospital of Philadelphia and Westat, Data Coordinating Center
  • Jonathan Spergel, MD, PhD, Children’s Hospital of Philadelphia
• The FARE Patient Registry 
  • Dylan Klomparens, MS, FARE
• Accelerating Research Via the FARE Clinical Network & Patient Registry
  • Jennifer Bufford, MS, FARE
• Live Panel Discussion

4:00 p.m. Break

5:00 p.m. Keynote Address – NIAID Perspective

• Introduction and State of the NIAID Food Allergy Portfolio
  • Alkis Togias, MD, National Institute of Allergy and Infectious Disease
• Food Allergy Prevention
  • Patricia Fulkerson, MD, PhD, National Institute of Allergy and Infectious Disease
• Immunotherapy in Food Allergy – the Quest for Tolerance
  • Amanda Rudman-Spergel, MD, National Institute of Allergy and Infectious Disease
• Live Panel Discussion
  • Alkis Togias, MD, Lisa Wheatley, MD, MPH, and colleagues

6:15 p.m. Special Panel Discussion

• Implementation of Prevention
  • Moderated by: Christina Ciaccio, MD, MSc, UChicago Medicine
  • Helen Brough, PhD, King’s College London
  • Marion Groetch, MS, RD, CDN, Icahn School of Medicine at Mount Sinai
  • Kirsi Jarvinen-Seppo, MD, PhD, University of Rochester Medical Center
  • Bruce Lanser, MD, MPH, National Jewish Health

 

Day 3 - Wednesday, October 20, 2021

 

11:00 a.m. Keynote Address – King’s College London Research Activities

• Translating LEAP into a Public Health Intervention
  • Graham Roberts, PhD, University of Southampton
• Learning Early about Peanut Allergy Trial: What Linear Allergenic Epitope Profiling Can Tell us
  • Hugh Sampson, MD, Icahn School of Medicine at Mount Sinai
• The Different Phenotypes of Peanut Allergy: The Resolution of Early Peanut Allergy
  • Ru-Xin Foong, MD, King’s College London
• Live Panel Discussion
  • Ru-Xin Foong, MD, King’s College London
  • Gideon Lack, MA, MBBCH, FRCP CH, MD, King’s College London
  • Hugh Sampson, MD, Icahn School of Medicine at Mount Sinai

12:00 p.m. Break

1:00 p.m. Innovative Treatments

• Reimagining the Treatment of Food Allergy to Transform Patient Lives
  • Ashley Dombkowski, PhD, AllAdapt
• Reengineering the Early-life Gut Microbiome to Prevent Allergy & Asthma
  • Susan Lynch, PhD, UC San Francisco
• VLP-Peanut: Route to Clinical Development
  • Pieter-Jan de Kam, PhD, Allergy Therapeutics
• Using AI and Protein Engineering to Redesign Food Proteins for Food and Therapeutics
  • Anat Binur, PhD, Ukko
• Live Panel Discussion

3:00 p.m. Break

4:00 p.m. Prevention

• Start Eating Early Diet (SEED) Study
  • Ruchi Gupta, MD, MPH, Northwestern University
• Maternal Diet During Pregnancy in Allergy Prevention: Beyond food allergens
  • Carina Venter, PhD, RD, Children’s Hospital Colorado
• Potential Mechanism of Action for Atopic Disease Prevention
  • Bethany Henrick, PhD, Evolve BioSystems
• Live Panel Discussio

6:15 p.m. Special Panel Discussion

• Do Something Now or Wait?
  • Moderated by: Scott Sicherer, MD, Icahn School of Medicine at Mount Sinai
  • Corinne Keet, MD, University of North Carolina
  • Anna Nowak-Wegrzyn, MD, PhD, NYU Langone
  • Wayne Shreffler, MD, PhD, Massachusetts General Hospital
  • Brian Vickery, MD, Emory University

7:15 p.m. Closing Remarks 

• Mary Weiser, Chair, FARE Board of Directors